Anika Therapeutics: Q2 Earnings Insights

Anika Therapeutics ANIK reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Anika Therapeutics beat estimated earnings by 47.83%, reporting an EPS of $-0.12 versus an estimate of $-0.23.

Revenue was up $1.51 million from the same period last year.

Last quarter the company beat on EPS by $0.25 which was followed by a 2.24% increase in the share price the next day.

Here's a look at Anika Therapeutics's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-0.36	-0.25	-0.21	-0.06
EPS Actual	-0.11	-0.23	0.05	0.09
Revenue Estimate	32.90M	32.05M	36.32M	34.76M
Revenue Actual	36.69M	35.82M	39.54M	38.15M

To track all earnings releases for Anika Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar